Literature DB >> 1979508

Adrenalectomy abolishes antagonism of alpha-adrenoceptor-mediated hypotension by a beta-blocker in conscious rats.

R Tabrizchi1, C C Pang.   

Abstract

1. The effects of a single bolus injection of propranolol, atenolol or ICI 118,551, non-selective beta-, selective beta 1- and selective beta 2-adrenoceptor antagonists, respectively, on mean arterial pressure (MAP) and plasma catecholamine concentrations were examined in seven groups of conscious and unrestrained adrenalectomized rats receiving a continuous infusion of the alpha-adrenoceptor antagonist phentolamine. In all rats adrenaline was undetectable in the plasma four days after adrenalectomy. 2. In the first three groups, phentolamine significantly decreased MAP and increased the plasma concentrations of noradrenaline. The injection of propranolol, atenolol or ICI 118,551 in Groups I, II and III, respectively, caused a small increase in MAP and a small, but not significant, decrease in plasma noradrenaline concentrations. 3. Groups IV, V and VI were given a continuous infusion of adrenaline for 1 h prior to the infusion of phentolamine, followed by a bolus injection of propranolol, atenolol or ICI 118,551, respectively. Group VII was treated similarly to IV, but was also given daily cortisone replacement after adrenalectomy. Adrenaline slightly, but not significantly, decreased MAP while phentolamine significantly decreased MAP and increased plasma noradrenaline concentrations in all groups. A subsequent injection of a beta-blocker caused a significant increase in MAP in each group and a slight decrease in the plasma level of noradrenaline which reached statistical significance in group VII. The pressor effect of propranolol was significantly greater in the cortisone-treated rats (Group VII) than in Group IV. 5. The results suggest that adrenaline and adrenocortical steroids are both involved in the antagonism of alpha-adrenoceptor-induced hypotension by a beta-blocker.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979508      PMCID: PMC1917676          DOI: 10.1111/j.1476-5381.1990.tb12714.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  CARDIOVASCULAR EFFECTS OF CATECHOLAMINES IN EXPERIMENTAL ADRENAL INSUFFICIENCY.

Authors:  A M LEFER; D C SUTFIN
Journal:  Am J Physiol       Date:  1964-05

2.  Interaction of glucocorticoids with glucagon and epinephrine in the control of gluconeogenesis and glycogenolysis in liver and of lipolysis in adipose tissue.

Authors:  J H Exton; N Friedmann; E H Wong; J P Brineaux; J D Corbin; C R Park
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

3.  Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity.

Authors:  L D Schaeffer; M Chenoweth; A Dunn
Journal:  Biochim Biophys Acta       Date:  1969-11-18

4.  On the pressor action of propranolol in the rat.

Authors:  J Yamamoto; A Sekiya
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-06

5.  Further observations on the pressor action of propranolol.

Authors:  S O Kayaalp; R K Türker
Journal:  Br J Pharmacol Chemother       Date:  1967-08

6.  A relatively nonspecific supersensitivity in aortic strips resulting from pretreatment with reserpine.

Authors:  P M Hudgins; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

7.  On the mechanism of the pressor response due to propranolol.

Authors:  N K Dasgupta
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

8.  Pressor action of beta blocking agents in rats.

Authors:  D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1970-07       Impact factor: 2.273

9.  Further studies on the effects of reserpine pretreatment on rabbit aorta: calcium and histologic changes.

Authors:  P M Hudgins; T M Harris
Journal:  J Pharmacol Exp Ther       Date:  1970-12       Impact factor: 4.030

10.  Mechanism of the antagonism of the hypotensive action of guanethidine by propranolol.

Authors:  R S Grewal; C L Kaul
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.